XML 22 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenues, net $ 109,246 $ 135,893
Cost of revenues 75,617 88,952
Gross profit 33,629 46,941
Operating expense:    
General and administrative 35,454 41,756
Depreciation and amortization 10,280 20,529
Research and development 4,269 4,126
Total operating expense 50,003 66,411
Loss from operations (16,374) (19,470)
Other (expense) income:    
Interest expense, net (10,032) (10,252)
Other income (expense), net 1,075 (727)
Loss on warrant issuance (578) 0
Change in fair value of common warrants 1,394 0
Total other expense (8,356) (10,774)
Loss before income taxes (24,730) (30,244)
Income tax benefit 920 1,909
Net loss (23,810) (28,335)
Fixed dividends - Series B Preferred (1,269) (1,269)
Net loss attributable to common stockholders - basic (25,079) (29,604)
Net loss attributable to common stockholders - diluted (25,079) (29,604)
Comprehensive loss:    
Net loss (23,810) (28,335)
Other comprehensive loss:    
Foreign currency translation adjustment 2,325 (1,074)
Total comprehensive loss $ (21,485) $ (29,409)
Net loss per common share – basic (in dollars per share) $ (39.74) $ (90.69)
Net loss per common share – diluted (in dollars per share) $ (39.74) $ (90.69)
Weighted average number of common shares outstanding – basic (in shares) 631,091 326,439
Weighted average number of common shares outstanding – diluted (in shares) 631,091 326,439
Nonrelated Party    
Other (expense) income:    
Change in fair value of derivative liabilities $ (4) $ 205
Related Party    
Other (expense) income:    
Change in fair value of derivative liabilities $ (211) $ 0